COMMUNIQUÉS West-GlobeNewswire

-
Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public Offering
23/09/2019 -
Spineway : Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held on 03 October 2019
23/09/2019 -
SPINEWAY : Convocation à l'Assemblée Générale Mixte du 3 octobre 2019
23/09/2019 -
Delcath Systems to Participate in Upcoming Investor Conferences
23/09/2019 -
Ellen AB inleder ett samarbete med Åhléns
23/09/2019 -
Guardion Health Sciences Acquires the NutriGuard Brand of Products
23/09/2019 -
Coretrust Capital Partners and Connectivity Wireless Create Smart Building at FourFortyFour South Flower
23/09/2019 -
Ozop Surgical Corp. Recognized as Most Innovative Surgical Implants & Instrumentation Manufacturer - USA by GHP
23/09/2019 -
Solos Introduces MammoView at ABSICON
23/09/2019 -
INmune Bio to Present XPro1595 for Treating Neuroinflammation in Alzheimer’s Disease at 2019 Alzheimer’s Association International Conference (AAIC) Satellite Symposium
23/09/2019 -
Nkarta Therapeutics Named as a “Fierce 15” Biotechnology Company of 2019
23/09/2019 -
FDA Grants Pediatric Disease Designation for Mateon’s OT101
23/09/2019 -
Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Patients
23/09/2019 -
Konica Minolta Healthcare CEO David Widmann to Share Insights on Creating Successful Strategic Partnerships at Health Connect South 2019 Annual Meeting
23/09/2019 -
Flexion Therapeutics Sponsors a Memorial to the Victims of the Opioid Crisis to Raise Awareness of the Tragic Consequences of the Opioid Epidemic Across the U.S.
23/09/2019 -
Onconova Therapeutics, Inc. Announces $3.4 Million Registered Direct Offering of Common Stock
23/09/2019 -
Transactions under Novozymes’ stock buyback program
23/09/2019 -
Abeona Therapeutics Provides Regulatory Update Ahead of Pivotal Phase 3 Clinical Trial for EB-101 in Recessive Dystrophic Epidermolysis Bullosa
23/09/2019 -
Cannabix Technologies Expands Marijuana Breathalyzer Portfolio with Licensing of UBC Technology for Workplace and Parental Use
23/09/2019
Pages